Unknown

Dataset Information

0

Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury.


ABSTRACT: Efficient in vivo delivery of anti-inflammatory proteins to modulate the microenvironment of an injured spinal cord and promote neuroprotection and functional recovery is a great challenge. Nucleoside-modified messenger RNA (mRNA) has become a promising new modality that can be utilized for the safe and efficient delivery of therapeutic proteins. Here, we used lipid nanoparticle (LNP)-encapsulated human interleukin-10 (hIL-10)-encoding nucleoside-modified mRNA to induce neuroprotection and functional recovery following rat spinal cord contusion injury. Intralesional administration of hIL-10 mRNA-LNP to rats led to a remarkable reduction of the microglia/macrophage reaction in the injured spinal segment and induced significant functional recovery compared to controls. Furthermore, hIL-10 mRNA treatment induced increased expression in tissue inhibitor of matrix metalloproteinase 1 and ciliary neurotrophic factor levels in the affected spinal segment indicating a time-delayed secondary effect of IL-10 5 d after injection. Our results suggest that treatment with nucleoside-modified mRNAs encoding neuroprotective factors is an effective strategy for spinal cord injury repair.

SUBMITTER: Gal L 

PROVIDER: S-EPMC10013810 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury.

Gál László L   Bellák Tamás T   Marton Annamária A   Fekécs Zoltán Z   Weissman Drew D   Török Dénes D   Biju Rachana R   Vizler Csaba C   Kristóf Rebeka R   Beattie Mitchell B MB   Lin Paulo J C PJC   Pardi Norbert N   Nógrádi Antal A   Pajer Krisztián K  

Research (Washington, D.C.) 20230309


Efficient in vivo delivery of anti-inflammatory proteins to modulate the microenvironment of an injured spinal cord and promote neuroprotection and functional recovery is a great challenge. Nucleoside-modified messenger RNA (mRNA) has become a promising new modality that can be utilized for the safe and efficient delivery of therapeutic proteins. Here, we used lipid nanoparticle (LNP)-encapsulated human interleukin-10 (hIL-10)-encoding nucleoside-modified mRNA to induce neuroprotection and funct  ...[more]

Similar Datasets

| S-EPMC6648195 | biostudies-literature
| S-EPMC6420421 | biostudies-literature
| S-EPMC8414904 | biostudies-literature
| S-EPMC7425521 | biostudies-literature
| S-EPMC8820714 | biostudies-literature
| S-EPMC9253790 | biostudies-literature
| S-EPMC6489327 | biostudies-literature
| S-EPMC7940162 | biostudies-literature
| S-EPMC6028604 | biostudies-literature
| S-EPMC9537842 | biostudies-literature